Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD515 for Xerostomia in Advanced Cancer
NCT01331746Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in xerostomia comparing APD515 Sequence with Placebo Sequence (2 arms). Primary endpoint: Subjective scoring of mouth dryness at 1 week. Started Sep 2011; status: completed.
02
Drugs
bethanechol
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT01331746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01331746.